BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9844041)

  • 1. Mapping of topoisomerase II alpha epitopes recognized by autoantibodies in idiopathic pulmonary fibrosis.
    Grigolo B; Mazzetti I; Borzì RM; Hickson ID; Fabbri M; Fasano L; Meliconi R; Facchini A
    Clin Exp Immunol; 1998 Dec; 114(3):339-46. PubMed ID: 9844041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to topoisomerase II in idiopathic pulmonary fibrosis.
    Meliconi R; Negri C; Borzì RM; Facchini A; Sturani C; Fasano L; Fabbri M; Astaldi Ricotti GC
    Clin Rheumatol; 1993 Sep; 12(3):311-5. PubMed ID: 8258229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease.
    Meliconi R; Bestagno M; Sturani C; Negri C; Galavotti V; Sala C; Facchini A; Ciarrocchi G; Gasbarrini G; Astaldi Ricotti GC
    Clin Exp Immunol; 1989 May; 76(2):184-9. PubMed ID: 2547538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation-associated nuclear antigen Ki-S1 is identical with topoisomerase II alpha. Delineation of a carboxy-terminal epitope with peptide antibodies.
    Boege F; Andersen A; Jensen S; Zeidler R; Kreipe H
    Am J Pathol; 1995 Jun; 146(6):1302-8. PubMed ID: 7539979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-Cell epitope mapping of DNA topoisomerase I defines epitopes strongly associated with pulmonary fibrosis in systemic sclerosis.
    Rizou C; Ioannidis JP; Panou-Pomonis E; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM; Vlachoyiannopoulos PG
    Am J Respir Cell Mol Biol; 2000 Mar; 22(3):344-51. PubMed ID: 10696071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-topoisomerase II alpha autoantibodies in systemic sclerosis-association with pulmonary hypertension and HLA-B35.
    Grigolo B; Mazzetti I; Meliconi R; Bazzi S; Scorza R; Candela M; Gabrielli A; Facchini A
    Clin Exp Immunol; 2000 Sep; 121(3):539-43. PubMed ID: 10971522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mapping of epitopes on melanocyte-specific protein Pmel17 which are recognized by autoantibodies in patients with vitiligo.
    Kemp EH; Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP
    Clin Exp Immunol; 2001 Jun; 124(3):509-15. PubMed ID: 11472416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of monoclonal antibodies to a recombinant human topoisomerase II polypeptide.
    Robinson RG; Rapp L; Bowdish KJ; Graham MA; Huff AC; Coughlin SA
    Hybridoma; 1993 Aug; 12(4):407-15. PubMed ID: 8244417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients.
    Raju R; Foote J; Banga JP; Hall TR; Padoa CJ; Dalakas MC; Ortqvist E; Hampe CS
    J Immunol; 2005 Dec; 175(11):7755-62. PubMed ID: 16301686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a lipoyl domain-independent B-cell autoepitope on the human branched-chain acyltransferase in primary biliary cirrhosis and overlap syndrome with autoimmune hepatitis.
    Csepregi A; Obermayer-Straub P; Kneip S; Kayser A; Loges S; Schmidt E; Nemesánszky E; Szalay F; Manns MP; Strassburg CP
    Clin Dev Immunol; 2003; 10(2-4):173-81. PubMed ID: 14768949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine specificity of autoantibodies to La/SSB: epitope mapping, and characterization.
    Tzioufas AG; Yiannaki E; Sakarellos-Daitsiotis M; Routsias JG; Sakarellos C; Moutsopoulos HM
    Clin Exp Immunol; 1997 May; 108(2):191-8. PubMed ID: 9158085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human DNA topoisomerase II as an autoantigen recognized by patients with IDDM.
    Chang YH; Hwang J; Shang HF; Tsai ST
    Diabetes; 1996 Apr; 45(4):408-14. PubMed ID: 8603760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine specificity of autoantibodies to calreticulin: epitope mapping and characterization.
    Eggleton P; Ward FJ; Johnson S; Khamashta MA; Hughes GR; Hajela VA; Michalak M; Corbett EF; Staines NA; Reid KB
    Clin Exp Immunol; 2000 May; 120(2):384-91. PubMed ID: 10792392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique epitopes for carbonic anhydrase II autoantibodies related to autoimmune retinopathy and cancer-associated retinopathy.
    Adamus G; Yang S; Weleber RG
    Exp Eye Res; 2016 Jun; 147():161-168. PubMed ID: 27185162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody specificities of Thai and Australian scleroderma sera with topoisomerase I recombinant fusion proteins.
    Cram DS; Fisicaro N; McNeilage LJ; Coppel RL; Harrison LC
    J Immunol; 1993 Dec; 151(12):6872-81. PubMed ID: 7505017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
    Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
    Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis.
    Dubel L; Tanaka A; Leung PS; Van de Water J; Coppel R; Roche T; Johanet C; Motokawa Y; Ansari A; Gershwin ME
    Hepatology; 1999 Apr; 29(4):1013-8. PubMed ID: 10094940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mapping of linear B-cell epitope regions in the extracellular parts of the desmoglein 1 and 3 proteins: recognition of immobilized peptides by pemphigus patients' serum autoantibodies.
    Szabados H; Bősze S; Silló P; Kárpáti S; Hudecz F; Uray K
    J Pept Sci; 2013 Feb; 19(2):84-94. PubMed ID: 23297065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3.
    Recke A; Regensburger AK; Weigold F; Müller A; Heidecke H; Marschner G; Hammers CM; Ludwig RJ; Riemekasten G
    Front Immunol; 2018; 9():428. PubMed ID: 29623076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.